Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiyun Yan

Showing results (21-30 of 202) with videos related to

Pageof 21
Sort By:
RSC Advances|May 2, 2022
Nanozyme-based catalytic theranosticsYanan Zhang, Yiliang Jin, Haixia Cui, et al.
Frontiers in Bioengineering and Biotechnology|March 3, 2020
Nanozymes: A New Disease Imaging StrategyPeixia Wang, Tao Wang, Juanji Hong, et al.
Biomaterials Science|February 27, 2023
Transferrin receptor 1 targeted nanomedicine for brain tumor therapyJianru Li, Zixia Zhang, Baoli Zhang, et al.
Exploration (Beijing, China)|June 27, 2023
Nanozyme for tumor therapy: Surface modification mattersGuoheng Tang, Jiuyang He, Juewen Liu, et al.
Theranostics|January 7, 2020
Ferritins as natural and artificial nanozymes for theranosticsBing Jiang, Long Fang, Kongming Wu, et al.
Advanced Drug Delivery Reviews|July 31, 2021
Ferritin nanocage: A promising and designable multi-module platform for constructing dynamic nanoassembly-based drug nanocarrierBaoli Zhang, Guoheng Tang, Jiuyang He, et al.
ACS Nano|January 12, 2024
Exploring the Specificity of NanozymesHuizhen Fan, Ruofei Zhang, Kelong Fan, et al.
Cancer Investigation|December 13, 2006
Suppression of human hepatoma growth in vivo by a monoclonal antibody against a Mr 45,000 proteinYun Lin, Jing Feng, Dongling Yang, et al.
Nano Letters|November 2, 2019
Fenozyme Protects the Integrity of the Blood-Brain Barrier against Experimental Cerebral MalariaShuai Zhao, Hongxia Duan, Yili Yang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 23, 2003
Pre-eclampsia is associated with the failure of melanoma cell adhesion molecule (MCAM/CD146) expression by intermediate trophoblastQin Liu, Xiyun Yan, Yang Li, et al.
Pageof 21

Showing results (21-30 of 202) with videos related to

Sort By:
Pageof 21
RSC Advances|May 2, 2022
Nanozyme-based catalytic theranosticsYanan Zhang, Yiliang Jin, Haixia Cui, et al.
Frontiers in Bioengineering and Biotechnology|March 3, 2020
Nanozymes: A New Disease Imaging StrategyPeixia Wang, Tao Wang, Juanji Hong, et al.
Biomaterials Science|February 27, 2023
Transferrin receptor 1 targeted nanomedicine for brain tumor therapyJianru Li, Zixia Zhang, Baoli Zhang, et al.
Exploration (Beijing, China)|June 27, 2023
Nanozyme for tumor therapy: Surface modification mattersGuoheng Tang, Jiuyang He, Juewen Liu, et al.
Theranostics|January 7, 2020
Ferritins as natural and artificial nanozymes for theranosticsBing Jiang, Long Fang, Kongming Wu, et al.
Advanced Drug Delivery Reviews|July 31, 2021
Ferritin nanocage: A promising and designable multi-module platform for constructing dynamic nanoassembly-based drug nanocarrierBaoli Zhang, Guoheng Tang, Jiuyang He, et al.
ACS Nano|January 12, 2024
Exploring the Specificity of NanozymesHuizhen Fan, Ruofei Zhang, Kelong Fan, et al.
Cancer Investigation|December 13, 2006
Suppression of human hepatoma growth in vivo by a monoclonal antibody against a Mr 45,000 proteinYun Lin, Jing Feng, Dongling Yang, et al.
Nano Letters|November 2, 2019
Fenozyme Protects the Integrity of the Blood-Brain Barrier against Experimental Cerebral MalariaShuai Zhao, Hongxia Duan, Yili Yang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 23, 2003
Pre-eclampsia is associated with the failure of melanoma cell adhesion molecule (MCAM/CD146) expression by intermediate trophoblastQin Liu, Xiyun Yan, Yang Li, et al.
Pageof 21